Skip to Main Content

Paper Details

Drug utilization analysis of osteoporosis medications in seven European electronic health databases.
Osteoporos Int
1
2023
Patients, alendronate, bisphosphonates, denosumab, estrogen, estrogen receptor, hypertension, osteoporosis, patients, teriparatide
Author NameAffiliation
Eng Hooi TanUniversity of Oxford
Mees MosseveldErasmus University Medical Centre
Mees MosseveldErasmus University Medical Centre
Carlen ReyesFundacio Institut Universitari Per a La Recerca a L'Atencio Primaria de Salut Jordi Gol I Gurina (IDIAPJGol)
Marcel de WildeErasmus University Medical Centre
Marcel de WildeErasmus University Medical Centre
Mar??a Arag??nFundacio Institut Universitari Per a La Recerca a L'Atencio Primaria de Salut Jordi Gol I Gurina (IDIAPJGol)
Mar??a Arag??nFundacio Institut Universitari Per a La Recerca a L'Atencio Primaria de Salut Jordi Gol I Gurina (IDIAPJGol)
Daniel Prieto-AlhambraUniversity of Oxford
Daniel Prieto-AlhambraErasmus University Medical Centre
Daniel Prieto-AlhambraUniversity of Oxford
Daniel Prieto-AlhambraErasmus University Medical Centre
  • 1 - 12

Datasets

Release 1.2